0000899243-18-016225.txt : 20180612 0000899243-18-016225.hdr.sgml : 20180612 20180612175305 ACCESSION NUMBER: 0000899243-18-016225 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180608 FILED AS OF DATE: 20180612 DATE AS OF CHANGE: 20180612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Naydenov Jordan G CENTRAL INDEX KEY: 0001469618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 18895424 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-08 0 0001175680 CytoDyn Inc. CYDY 0001469618 Naydenov Jordan G 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 1 0 0 0 Stock Options (right to buy) 0.49 2018-06-08 4 A 0 100000 0.00 A 2028-06-08 Common Stock 100000 100000 D The options will vest in four equal quarterly installments commencing on September 1, 2018. /s/ Michael D. Mulholland, as attorney-in-fact 2018-06-12